Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.

Zipse MM, Tzou WS, Schuller JL, Aleong RG, Varosy PD, Tompkins C, Borne RT, Tumolo AZ, Sandhu A, Kim D, Freeman AM, Weinberger HD, Maier LA, Sung RK, Nguyen DT, Sauer WH.

J Cardiovasc Electrophysiol. 2019 Oct;30(10):1939-1948. doi: 10.1111/jce.14058. Epub 2019 Jul 23.

PMID:
31257683
2.

Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis.

Ryan SM, Fingerlin TE, Mroz M, Barkes B, Hamzeh N, Maier LA, Carlson NE.

Eur Respir J. 2019 Aug 29;54(2). pii: 1900371. doi: 10.1183/13993003.00371-2019. Print 2019 Aug.

PMID:
31196947
3.

Protective role of B cells in sterile particulate-induced lung injury.

Atif SM, Mack DG, McKee AS, Rangel-Moreno J, Martin AK, Getahun A, Maier LA, Cambier JC, Tuder R, Fontenot AP.

JCI Insight. 2019 May 16;5. pii: 125494. doi: 10.1172/jci.insight.125494.

4.

Reply to Hall et al.: Hypersensitivity Pneumonitis Mortality by Industry and Occupation.

Fernández Pérez ER, Sprunger D, Ratanawatkul P, Maier LA, Huie TJ, Swigris JJ, Solomon JJ, Mohning M, Keith RC, Brown KK.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):518-519. doi: 10.1164/rccm.201904-0876LE. No abstract available.

5.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

6.

Occupational Lung Disease.

Perlman DM, Maier LA.

Med Clin North Am. 2019 May;103(3):535-548. doi: 10.1016/j.mcna.2018.12.012. Epub 2019 Mar 7. Review.

PMID:
30955520
7.

Increasing Hypersensitivity Pneumonitis-related Mortality in the United States from 1988 to 2016.

Fernández Pérez ER, Sprunger DB, Ratanawatkul P, Maier LA, Huie TJ, Swigris JJ, Solomon JJ, Mohning MP, Keith RC, Brown KK.

Am J Respir Crit Care Med. 2019 May 15;199(10):1284-1287. doi: 10.1164/rccm.201807-1258LE. No abstract available.

PMID:
30768910
8.

Polymorphism of FCGR3A gene in chronic beryllium disease.

Liu B, Maier LA, Hamzeh N, MacPhail K, Mroz MM, Liu H, Li L.

Genes Immun. 2019 Jul;20(6):493-499. doi: 10.1038/s41435-018-0046-8. Epub 2018 Sep 24.

9.

DNA Methylation Changes in Lung Immune Cells Are Associated with Granulomatous Lung Disease.

Yang IV, Konigsberg I, MacPhail K, Li L, Davidson EJ, Mroz PM, Hamzeh N, Gillespie M, Silveira LJ, Fingerlin TE, Maier LA.

Am J Respir Cell Mol Biol. 2019 Jan;60(1):96-105. doi: 10.1165/rcmb.2018-0177OC.

PMID:
30141971
10.

Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?

Levy A, Hamzeh N, Maier LA.

F1000Res. 2018 May 16;7. pii: F1000 Faculty Rev-600. doi: 10.12688/f1000research.11068.1. eCollection 2018. Review.

11.

Introduction to the 60th Annual Thomas L. Petty Aspen Lung Conference. Environment and Global Lung Health: Exposure, Susceptibility, and Intervention.

Maier LA, Brody AR, Schwartz DA.

Ann Am Thorac Soc. 2018 Apr;15(Suppl 2):S61-S63. doi: 10.1513/AnnalsATS.201707-576MG. No abstract available.

12.

Effect of inhaled corticosteroids on lung function in chronic beryllium disease.

Mroz MM, Ferguson JH, Faino AV, Mayer A, Strand M, Maier LA.

Respir Med. 2018 May;138S:S14-S19. doi: 10.1016/j.rmed.2018.01.009. Epub 2018 Feb 5.

13.

Clinical tool for disease phenotyping in granulomatous lung disease.

Silveira LJ, Strand M, Van Dyke MV, Mroz MM, Faino AV, Dabelea DM, Maier LA, Fingerlin TE.

PLoS One. 2017 Nov 16;12(11):e0188119. doi: 10.1371/journal.pone.0188119. eCollection 2017.

14.

5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.

Day BJ, Huang J, Barkes BQ, Gillespie M, Li L, Maier LA.

Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27.

PMID:
29080069
15.

Application of "Omics" and Systems Biology to Sarcoidosis Research.

Crouser ED, Fingerlin TE, Yang IV, Maier LA, Nana-Sinkam P, Collman RG, Kaminski N.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S445-S451. doi: 10.1513/AnnalsATS.201707-567OT. Review.

16.

Executive Summary of the NHLBI Workshop Report: Leveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve Outcomes.

Maier LA, Crouser ED, Martin WJ 2nd, Eu J.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S415-S420. doi: 10.1513/AnnalsATS.201707-563OT. Review.

17.

Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci.

McIntosh LA, Marion MC, Sudman M, Comeau ME, Becker ML, Bohnsack JF, Fingerlin TE, Griffin TA, Haas JP, Lovell DJ, Maier LA, Nigrovic PA, Prahalad S, Punaro M, Rosé CD, Wallace CA, Wise CA, Moncrieffe H, Howard TD, Langefeld CD, Thompson SD.

Arthritis Rheumatol. 2017 Nov;69(11):2222-2232. doi: 10.1002/art.40216. Epub 2017 Oct 12.

18.

Exosomal MicroRNA for Detection of Cardiac Sarcoidosis.

Crouser ED, Hamzeh NY, Maier LA, Julian MW, Gillespie M, Rahman M, Baxter D, Wu X, Nana-Sinkam SP, Wang K.

Am J Respir Crit Care Med. 2017 Oct 1;196(7):931-934. doi: 10.1164/rccm.201611-2183LE. No abstract available.

19.

Response.

Maier LA, Liu H, Patel D, Welch A, Wilson C, Mroz M, Li L, Rose C, VanDyke M, Swigris J, Hamzeh N.

Chest. 2016 Dec;150(6):1423-1424. doi: 10.1016/j.chest.2016.10.004. No abstract available.

20.

Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis.

Li L, Silveira LJ, Hamzeh N, Gillespie M, Mroz PM, Mayer AS, Fingerlin TE, Maier LA.

Eur Respir J. 2016 Jun;47(6):1797-808. doi: 10.1183/13993003.01469-2015. Epub 2016 Apr 21.

21.

Association Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999.

Liu H, Patel D, Welch AM, Wilson C, Mroz MM, Li L, Rose CS, Van Dyke M, Swigris JJ, Hamzeh N, Maier LA.

Chest. 2016 Aug;150(2):289-98. doi: 10.1016/j.chest.2016.01.020. Epub 2016 Jan 30.

22.

Genetics of Sarcoidosis.

Fingerlin TE, Hamzeh N, Maier LA.

Clin Chest Med. 2015 Dec;36(4):569-84. doi: 10.1016/j.ccm.2015.08.002. Epub 2015 Oct 1. Review.

PMID:
26593134
23.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol.

Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF; GRADS Sarcoidosis Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1561-71. doi: 10.1513/AnnalsATS.201503-172OT.

24.

Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.

Li L, Hamzeh N, Gillespie M, Elliott J, Wang J, Gottschall EB, Mroz PM, Maier LA.

PLoS One. 2015 Feb 17;10(2):e0117276. doi: 10.1371/journal.pone.0117276. eCollection 2015.

25.

Chronic respiratory diseases: challenges in diagnosis and prevention.

Varkey B, Maier LA.

Curr Opin Pulm Med. 2015 Mar;21(2):111-3. doi: 10.1097/MCP.0000000000000146. No abstract available.

PMID:
25621561
26.

p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation.

Li L, Huang Z, Gillespie M, Mroz PM, Maier LA.

Hum Immunol. 2014 Dec;75(12):1155-62. doi: 10.1016/j.humimm.2014.10.010. Epub 2014 Oct 22.

27.

An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.

Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, Schuler CR, Takaro TK, Wambach PF; ATS Ad Hoc Committee on Beryllium Sensitivity and Chronic Beryllium Disease.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59. doi: 10.1164/rccm.201409-1722ST. Review.

PMID:
25398119
28.

Efficacy of mycophenolate mofetil in sarcoidosis.

Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA.

Respir Med. 2014 Nov;108(11):1663-9. doi: 10.1016/j.rmed.2014.09.013. Epub 2014 Sep 28.

29.

Sarcoidosis and chronic beryllium disease: similarities and differences.

Mayer AS, Hamzeh N, Maier LA.

Semin Respir Crit Care Med. 2014 Jun;35(3):316-29. doi: 10.1055/s-0034-1377059. Epub 2014 Jul 9. Review.

PMID:
25007084
30.

Identification of multiple public TCR repertoires in chronic beryllium disease.

Bowerman NA, Falta MT, Mack DG, Wehrmann F, Crawford F, Mroz MM, Maier LA, Kappler JW, Fontenot AP.

J Immunol. 2014 May 15;192(10):4571-80. doi: 10.4049/jimmunol.1400007. Epub 2014 Apr 9.

31.

Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.

Chain JL, Martin AK, Mack DG, Maier LA, Palmer BE, Fontenot AP.

J Immunol. 2013 Aug 15;191(4):1648-56. doi: 10.4049/jimmunol.1300282. Epub 2013 Jul 12.

32.

Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease.

Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GM, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP.

J Exp Med. 2013 Jul 1;210(7):1403-18.

33.

Developing effective health and safety training materials for workers in beryllium-using industries.

Mayer AS, Brazile WJ, Erb SA, Barker EA, Miller CM, Mroz MM, Maier LA, Van Dyke MV.

J Occup Environ Med. 2013 Jul;55(7):746-51. doi: 10.1097/JOM.0b013e3182972f1b.

PMID:
23787563
34.

Predictors of cardiac sarcoidosis using commonly available cardiac studies.

Freeman AM, Curran-Everett D, Weinberger HD, Fenster BE, Buckner JK, Gottschall EB, Sauer WH, Maier LA, Hamzeh NY.

Am J Cardiol. 2013 Jul 15;112(2):280-5. doi: 10.1016/j.amjcard.2013.03.027. Epub 2013 Apr 18.

PMID:
23602692
35.

Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

Maier LA, Barkes BQ, Mroz M, Rossman MD, Barnard J, Gillespie M, Martin A, Mack DG, Silveira L, Sawyer RT, Newman LS, Fontenot AP.

Respir Med. 2012 Dec;106(12):1810-3. doi: 10.1016/j.rmed.2012.08.014. Epub 2012 Sep 11. No abstract available.

36.

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA.

J Immunol. 2012 Oct 15;189(8):4014-23. doi: 10.4049/jimmunol.1200798. Epub 2012 Sep 12.

37.

The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.

Hines SE, Pacheco K, Maier LA.

Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):102-10. doi: 10.1097/ACI.0b013e3283511396. Review.

38.

Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression.

Martin AK, Mack DG, Falta MT, Mroz MM, Newman LS, Maier LA, Fontenot AP.

J Allergy Clin Immunol. 2011 Nov;128(5):1100-6.e1-5. doi: 10.1016/j.jaci.2011.08.022. Epub 2011 Sep 23.

39.

Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.

Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1680-8. doi: 10.1164/rccm.201002-0254OC. Epub 2011 Mar 11.

40.

Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.

Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL, Tankersley WG, Wells SM, Newman LS, Maier LA.

Occup Environ Med. 2011 Nov;68(11):842-8. doi: 10.1136/oem.2010.064220. Epub 2011 Apr 2.

41.

Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada.

Ribeiro M, Fritscher LG, Al-Musaed AM, Balter MS, Hoffstein V, Mazer BD, Maier LA, Liss GM, Tarlo SM.

Lung. 2011 Jun;189(3):233-41. doi: 10.1007/s00408-011-9285-4. Epub 2011 Mar 13.

PMID:
21400234
42.

SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease.

Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS.

Occup Environ Med. 2011 Oct;68(10):759-64. doi: 10.1136/oem.2010.058966. Epub 2011 Jan 27.

43.

Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Sawyer RT, Maier LA.

Biometals. 2011 Feb;24(1):1-17. doi: 10.1007/s10534-010-9376-3. Epub 2010 Oct 28. Review.

44.

Interpreting borderline BeLPT results.

Middleton DC, Mayer AS, Lewin MD, Mroz MM, Maier LA.

Am J Ind Med. 2011 Mar;54(3):205-9. doi: 10.1002/ajim.20909. Epub 2010 Oct 18.

45.

Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI.

Hum Mol Genet. 2010 Oct 15;19(20):4100-11. doi: 10.1093/hmg/ddq325. Epub 2010 Aug 3.

46.

Gene-environment interactions influence airways function in laboratory animal workers.

Pacheco KA, Rose CS, Silveira LJ, Van Dyke MV, Goelz K, MacPhail K, Maier LA.

J Allergy Clin Immunol. 2010 Aug;126(2):232-40. doi: 10.1016/j.jaci.2010.04.019. Epub 2010 Jun 25.

47.

Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.

Mack DG, Lanham AM, Falta MT, Palmer BE, Maier LA, Fontenot AP.

Am J Respir Crit Care Med. 2010 Jun 1;181(11):1241-9. doi: 10.1164/rccm.201001-0025OC. Epub 2010 Mar 18.

48.

CC chemokine receptor 5 gene polymorphisms in beryllium disease.

Sato H, Silveira L, Spagnolo P, Gillespie M, Gottschall EB, Welsh KI, du Bois RM, Newman LS, Maier LA.

Eur Respir J. 2010 Aug;36(2):331-8. doi: 10.1183/09031936.00107809. Epub 2010 Jan 14.

49.

Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.

Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ.

Am J Respir Cell Mol Biol. 2010 Oct;43(4):458-64. doi: 10.1165/rcmb.2009-0150OC. Epub 2009 Nov 9.

50.

Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.

Mroz MM, Maier LA, Strand M, Silviera L, Newman LS.

Am J Ind Med. 2009 Oct;52(10):762-73. doi: 10.1002/ajim.20736.

Supplemental Content

Loading ...
Support Center